MarkVCID  is a consortium of US academic medical centers whose mission is to identify and validate biomarkers for the small vessel diseases of the brain that produce vascular contributions to cognitive impairment and dementia (VCID).  The overall goal of the consortium is to deliver high-quality biomarkers ready for use in clinical trials aimed at generating scientific breakthroughs in our understanding and treatment of VCID.